Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-369234
Filing Date
2015-11-06
Accepted
2015-11-06 08:02:27
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d71519d10q.htm 10-Q 163751
2 EX-31.1 d71519dex311.htm EX-31.1 8763
3 EX-31.2 d71519dex312.htm EX-31.2 8761
4 EX-32.1 d71519dex321.htm EX-32.1 4706
  Complete submission text file 0001193125-15-369234.txt   1526919

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20150930.xml EX-101.INS 154753
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20150930.xsd EX-101.SCH 22915
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20150930_cal.xml EX-101.CAL 24538
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20150930_def.xml EX-101.DEF 140707
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20150930_lab.xml EX-101.LAB 214899
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20150930_pre.xml EX-101.PRE 162070
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 151202484
SIC: 2834 Pharmaceutical Preparations